AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...
Maxim downgraded Gilead (GILD) to Hold from Buy. The stock has appreciated significantly following a pullback in the first half of the year, ...
Maxim downgraded Gilead (GILD) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback